These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 30105078)
1. Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway. Liang Y; Zhang Y; Deng Y; Liang S; He Y; Chen Y; Liu C; Lin C; Han L; Tu G; Yang Q Evid Based Complement Alternat Med; 2018; 2018():9390786. PubMed ID: 30105078 [TBL] [Abstract][Full Text] [Related]
2. Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance. Jia KK; Pan SM; Ding H; Liu JH; Zheng YJ; Wang SJ; Pan Y; Kong LD Biomed Pharmacother; 2018 Jul; 103():1415-1428. PubMed ID: 29864926 [TBL] [Abstract][Full Text] [Related]
3. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats. Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414 [TBL] [Abstract][Full Text] [Related]
4. Chaihu-Shugan-San and absorbed meranzin hydrate induce anti-atherosclerosis and behavioral improvements in high-fat diet ApoE Li L; Yu AL; Wang ZL; Chen K; Zheng W; Zhou JJ; Xie Q; Yan HB; Ren P; Huang X Biomed Pharmacother; 2019 Jul; 115():108893. PubMed ID: 31022598 [TBL] [Abstract][Full Text] [Related]
5. p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats. Yang Q; Xu Y; Feng G; Hu C; Zhang Y; Cheng S; Wang Y; Gong X Afr J Tradit Complement Altern Med; 2014; 11(1):213-21. PubMed ID: 24653580 [TBL] [Abstract][Full Text] [Related]
6. [Screening of specific microRNA in hippocampus of depression model rats and intervention effect of Chaihu Shugan San]. Cao MQ; Chen DH; Zhang CH; Wu ZZ Zhongguo Zhong Yao Za Zhi; 2013 May; 38(10):1585-9. PubMed ID: 23947143 [TBL] [Abstract][Full Text] [Related]
7. Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress. Zhu X; Li T; Hu E; Duan L; Zhang C; Wang Y; Tang T; Yang Z; Fan R Front Pharmacol; 2021; 12():791097. PubMed ID: 35111057 [No Abstract] [Full Text] [Related]
8. Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. Jiang WN; Li D; Jiang T; Guo J; Chen YF; Wang J; Zhou Y; Yang CY; Tang CP Chin J Integr Med; 2018 Feb; 24(2):125-132. PubMed ID: 27164963 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia. Qiu XJ; Huang X; Chen ZQ; Ren P; Huang W; Qin F; Hu SH; Huang J; He J; Liu ZQ; Zhou HH J Ethnopharmacol; 2011 Sep; 137(1):205-13. PubMed ID: 21605652 [TBL] [Abstract][Full Text] [Related]
10. Liu Q; Sun NN; Wu ZZ; Fan DH; Cao MQ Neural Regen Res; 2018 May; 13(5):837-845. PubMed ID: 29863014 [TBL] [Abstract][Full Text] [Related]
11. [Study of the effect of liraglutide on the correlation between NLRP3 inflammasome and non-alcoholic fatty liver disease]. Ma ZZ; Ao N; Yang N; Yang J; Jin S; Du C; Du J Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):624-630. PubMed ID: 36038324 [No Abstract] [Full Text] [Related]
12. Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathway. Hou C; Jiang X; Sheng W; Zhang Y; Lin Q; Hong S; Zhao J; Wang T; Ye X J Ethnopharmacol; 2024 Jan; 319(Pt 2):117240. PubMed ID: 37777030 [TBL] [Abstract][Full Text] [Related]
13. [Effect of Shugan Jianpi Recipe on LXRα/FAS signaling pathway mediated hepatocyte fatty deposits in NAFLD rats]. Gong XW; Yang-Qin-He ; Yan HZ; Zhang YP; Huang J; Xu YJ; Zhang JW; Lin CM Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Dec; 34(12):1481-6. PubMed ID: 25632750 [TBL] [Abstract][Full Text] [Related]
14. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis. Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783 [TBL] [Abstract][Full Text] [Related]
15. Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and Lei S; Zhao S; Huang X; Feng Y; Li Z; Chen L; Huang P; Guan H; Zhang H; Wu Q; Chen B Front Pharmacol; 2022; 13():967623. PubMed ID: 36172180 [No Abstract] [Full Text] [Related]
16. Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3β/PTEN/Akt pathway. Fan Q; Liu Y; Sheng L; Lv S; Yang L; Zhang Z; Guo J; Fan Y; Hu D Biomed Pharmacother; 2023 Apr; 160():114385. PubMed ID: 36774722 [TBL] [Abstract][Full Text] [Related]
17. Chaihu Shugan prevents cholesterol gallstone formation by ameliorating the microbiota dysbiosis and metabolic disturbance in mice. Wang W; Zhang K; Liu B; Zhou T; Tang Y; Li Y Front Pharmacol; 2023; 14():1291236. PubMed ID: 38357365 [No Abstract] [Full Text] [Related]
18. Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut-Liver Axis in High-Fat Diet-Fed Rats. Zhao H; Gao X; Liu Z; Zhang L; Fang X; Sun J; Zhang Z; Sun Y Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432531 [TBL] [Abstract][Full Text] [Related]
19. Influence of progestational stress on BDNF and NMDARs in the hippocampus of male offspring and amelioration by Chaihu Shugan San. Xu YH; Wang XX; Wang MJ; Liu YY; Xue Z; Chen JX Biomed Pharmacother; 2021 Mar; 135():111204. PubMed ID: 33548869 [TBL] [Abstract][Full Text] [Related]
20. [Mechanism of Huanglian Wendan Decoction in improving impaired glucose tolerance based on skeletal muscle NLRP3/caspase-1/IL-1β, IL-18 pathway]. Dong WR; Li H; Li YF; Wang N; Ma BY; Lu GL; Xin XR; Chen BB Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4480-4487. PubMed ID: 34581053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]